NEWS & VIEWS

Global private equity and venture capital news and research

Posts Tagged ‘CRISPR’

24 April 2014

Versant invests $25m in Series A for gene editing business CRISPR

dna Versant Ventures has led a $25m Series A financing round for biopharmaceutical business CRISPR Therapeutics, which is currently working on a breakthrough gene editing technology.


Legals & Terms of UsePrivacy Policy


AltAssets is registered as a trademark of Investor Networks Limited (06695690).
Registered Office: Zetland House, 5-25 Scrutton St, London EC2A 4HJ
Content is © AltAssets 2000-2014